DUBLIN--(BUSINESS WIRE)--The "Cell Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global cell therapy market size reached US$ 9.17 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 27.05 Billion by 2027, exhibiting a CAGR of 19.76% during 2021-2027.
Companies Mentioned
- AlloSource
- Anterogen Co. Ltd.
- Cells for Cells
- Holostem Terapie Avanzate S.r.l.
- JCR Pharmaceuticals
- Kolon TissueGene Inc.
- MEDIPOST
- Mesoblast Limited
- NuVasive
- Stemedica Cell Technologies Inc.
- Stempeutics Research Pvt. Ltd
- Vericel Corporation
Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Cell therapy (CT) is the transplantation of human cells to replace or repair damaged tissues and cells. It comprises hematopoietic stem cells (HSC), skeletal muscle and mesenchymal stem cells, lymphocytes, and dendritic and pancreatic islet cells. It improves the immune system of the body to fight cancer cells.
Apart from this, cell therapy assists in treating various conditions, such as autoimmune and infectious diseases, urinary problems, damaged cartilage in joints, spinal cord injuries, a weakened immune system, and neurological disorders. At present, it is used to manufacture regenerative medicines for developing and applying new treatments to heal tissues and organs and restore functions lost due to aging, disease, and damage.
At present, there is a rise in the prevalence of various diseases, such as cancer and cardiac abnormalities, across the globe. This, along with the growing number of clinical studies for cell-based therapies, represents one of the key factors driving the market. Besides this, governing agencies of several countries are promoting clinical trials around the world, which is contributing to the growth of the market.
In addition, key market players are extensively investing in research and development (R&D) activities to introduce skin rejuvenation and tendon regeneration therapies. They are also focusing on developing direct cell reprogramming to replace lost neuronal tissues due to neurodegeneration or neurotrauma.
Moreover, there is an increase in the development of advanced genomic therapy techniques to treat various diseases, such as cystic fibrosis, heart disease, diabetes, hemophilia, and acquired immune deficiency syndrome (AIDS). This, coupled with the burgeoning healthcare industry, is propelling the growth of the market.
Apart from this, the rising demand for regenerative medicines to replace tissue or organs damaged by diseases, traumas, or congenital issues is bolstering the growth of the market.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global cell therapy market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on cell type, therapy type, therapeutic area and end user.
Breakup by Cell Type:
- Stem Cell
- Bone Marrow
- Blood
- Umbilical Cord-Derived
- Adipose-Derived Stem Cell
- Others
- Non-stem Cell
Breakup by Therapy Type:
- Autologous
- Allogeneic
Breakup by Therapeutic Area:
- Malignancies
- Musculoskeletal Disorders
- Autoimmune Disorders
- Dermatology
- Others
Breakup by End User:
- Hospitals and Clinics
- Academic and Research Institutes
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Key Questions Answered in This Report:
- How has the global cell therapy market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global cell therapy market?
- What are the key regional markets?
- What is the breakup of the market based on the cell type?
- What is the breakup of the market based on the therapy type?
- What is the breakup of the market based on the therapeutic area?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global cell therapy market and who are the key players?
- What is the degree of competition in the industry?
For more information about this report visit https://www.researchandmarkets.com/r/cwmpbw
